YI-HUA LIAOHSIEN-CHING CHIUHsiao G.-H.2019-12-052019-12-0519980001-5555https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031595650&doi=10.1080%2f000155598441927&partnerID=40&md5=19be5a2142dde4cd915037d849977295https://scholars.lib.ntu.edu.tw/handle/123456789/435138[SDGs]SDG2[SDGs]SDG3prednisolone; antiinflammatory agent; prednisolone; adult; case report; disease severity; erythrocyte sedimentation rate; human; letter; male; priority journal; prognosis; sarcoidosis; China; follow up; needle biopsy; oral drug administration; pathology; skin disease; Administration, Oral; Adult; Anti-Inflammatory Agents; Biopsy, Needle; China; Follow-Up Studies; Humans; Male; Prednisolone; Sarcoidosis; Skin Diseasesletter10.1080/00015559844192796893022-s2.0-0031595650